We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-6.86%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$166M
AUM Growth
+$8.35M
Cap. Flow
+$27.8M
Cap. Flow %
16.81%
Top 10 Hldgs %
40.91%
Holding
125
New
39
Increased
43
Reduced
18
Closed
15

Top Buys

Rank Stock Value
1
MA icon
Mastercard
MA
+$4.42M
2
IWD icon
iShares Russell 1000 Value ETF
IWD
+$3.73M
3
TGNA
TEGNA Inc
TGNA
+$3.12M
4
BCYC
Bicycle Therapeutics
BCYC
+$2.8M
5
TWTR
Twitter, Inc.
TWTR
+$2.75M

Top Sells

Rank Stock Value
1
PBCT
People's United Financial Inc
PBCT
+$3.92M
2
FIS icon
Fidelity National Information Services
FIS
+$3.85M
3
CERN
Cerner Corp
CERN
+$3.49M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$1.5M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$979K

Sector Composition

Rank Sector Weight
1 Healthcare 46.47%
2 Technology 22.39%
3 Financials 16.85%
4 Communication Services 4.29%
5 Consumer Discretionary 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
1
Dell
DELL
$276B
$16.4M 9.92%
355,444
– –
MA icon
2
Mastercard
MA
$487B
$11.7M 7.05%
37,024
+12,820
+53% +$4.42M
V icon
3
Visa
V
$689B
$8.52M 5.14%
43,257
+2,122
+5% +$439K
FISV
4
Fiserv Inc
FISV
$27.9B
$7.68M 4.64%
86,334
+3,048
+4% +$296K
MSDAU
5
DELISTED
MSD Acquisition Corp. Unit
MSDAU
$4.93M 2.98%
500,000
– –
KURA icon
6
Kura Oncology
KURA
$901M
$3.99M 2.41%
217,895
+70,062
+47% +$1.01M
CHNG
7
DELISTED
Change Healthcare Inc. Common Stock
CHNG
$3.74M 2.26%
162,100
– –
PYPL icon
8
PayPal
PYPL
$49.5B
$3.72M 2.25%
53,302
+2,584
+5% +$224K
COHR
9
DELISTED
Coherent Inc
COHR
$3.62M 2.19%
13,600
– –
IWD icon
10
iShares Russell 1000 Value ETF
IWD
$81.5B
$3.45M 2.09%
+23,825
New +$3.73M
CPNG icon
11
Coupang
CPNG
$28.6B
$3.27M 1.97%
256,264
– –
ATVI
12
DELISTED
Activision Blizzard
ATVI
$3.11M 1.88%
40,000
– –
CTXS
13
DELISTED
Citrix Systems Inc
CTXS
$3.05M 1.84%
31,400
– –
ACRS icon
14
Aclaris Therapeutics
ACRS
$750M
$3.04M 1.83%
217,528
+59,285
+37% +$831K
TGNA
15
DELISTED
TEGNA Inc
TGNA
$3.02M 1.82%
+144,000
New +$3.12M
TPTX
16
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$2.96M 1.79%
39,384
+18,347
+87% +$815K
FHN icon
17
First Horizon
FHN
$12.1B
$2.96M 1.79%
135,400
– –
FATE icon
18
Fate Therapeutics
FATE
$283M
$2.94M 1.78%
118,778
+54,113
+84% +$1.49M
CYTK icon
19
Cytokinetics
CYTK
$10.9B
$2.65M 1.6%
67,502
+1,733
+3% +$69.8K
BCYC
20
Bicycle Therapeutics
BCYC
$276M
$2.54M 1.53%
151,207
+132,909
+726% +$2.8M
TVTX icon
21
Travere Therapeutics
TVTX
$5.27B
$2.52M 1.52%
104,150
+71,649
+220% +$1.8M
TWTR
22
DELISTED
Twitter, Inc.
TWTR
$2.39M 1.44%
+64,000
New +$2.75M
GBT
23
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2.37M 1.43%
74,261
+23,176
+45% +$678K
RPTX
24
DELISTED
Repare Therapeutics
RPTX
$2.13M 1.29%
152,600
+9,225
+6% +$109K
APLS
25
DELISTED
Apellis Pharmaceuticals
APLS
$2.09M 1.26%
46,141
+9,248
+25% +$422K
1
2 3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
BHBT
Burke & Herbert Bank & Trust Alexandria, Virginia $362M AUM 20.5% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return

HighVista Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, HighVista Strategies held 125 positions worth $166M, up 5.3% from $157M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

HighVista Strategies deployed $27.8M of net new capital in Q2 2022, opening 39 new positions and adding to 43 existing holdings. Its largest new stake was iShares Russell 1000 Value ETF: 23,825 shares worth $3.45M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 44% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Protagonist Therapeutics, an estimated $551K trimmed.

  • HighVista Strategies's largest Q2 2022 buy was iShares Russell 1000 Value ETF: 23,825 shares worth $3.45M.
  • HighVista Strategies added most to Mastercard in Q2 2022, an estimated $4.42M increase.
  • HighVista Strategies's biggest Q2 2022 reduction was Protagonist Therapeutics, cutting an estimated $551K.
  • HighVista Strategies fully exited People's United Financial Inc in Q2 2022, selling an estimated $3.92M.
  • HighVista Strategies's ten largest holdings make up 41% of its $166M portfolio in Q2 2022.
  • HighVista Strategies opened 39 new positions and closed 15 in Q2 2022.
  • HighVista Strategies's portfolio value rose 5.3% quarter-over-quarter to $166M.

Based on HighVista Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.